Skip to main content
  • Saved

made a Post

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands

Source : https://doi.org/10.3389/fimmu.2019.02731

Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have led to a renewed interest for human leukocyte antigen class I (HLA-I) binding peptides, given their potential use as peptide vaccines. Databases of HLA-I binding peptides hold therefore information on therapeutic targets essential for understanding immunity.

Sign In or Register Today to Access This Content